To conduct an evaluation before and two years after the introduction of the Pneumococcal conjugate vaccine (PCV) to study the direct and indirect impact of PCV introduction on vaccine-type pneumococcal carriage among healthy Indonesian children under five years of age.

To further research how viral ovarian tumor protease (vOTU) activity is critical for replication and host tropism of nairoviruses.

To provide laboratory support for the analysis of immunogenicity and shedding of new oral Poliovirus vaccines in human clinical trials and related issues for polio endgame.

To build capacity of community-based organizations to strengthen vaccine confidence and acceptance within target populations by supporting evidence-based science on vaccinations, vaccine-preventable diseases and the importance of on-time vaccination.

To strengthen pregnancy surveillance and service delivery as part of the antenatal and postnatal care research collective at the Child Health and Mortality Prevention Surveillance site in Kenya.

To conduct research and analysis that will provide public health professionals, policy makers and legislators with an evidence-base to address gaps in care and service for Medicaid patients seeking STD care.

To continue implementation of a cryptococcal meningitis screen and treat program in the nine African countries to preemptively treat patients and avoid potential infection or death.

To understand the rectal muscosal effects of cross-sex hormone therapy among U.S. and Thai transgender woman.

To generate RSV genomic surveillance data from low- and middle-income countries leveraging the RSV Global Influenza Surveillance and Response System (GISRS) platform.

To show the health impact of low-cost, Indian-made rotavirus vaccines in high burden, low-income countries of Africa and Asia.